Conference May Boost WIPO Mandate On Food Security, Public Health 15/07/2009 by Kaitlin Mara for Intellectual Property Watch and William New 1 Comment A conference at the World Intellectual Property Organization exploring and clarifying the connection between its work and several major public policy issues ended Tuesday with a look at public health and food security.
WIPO Looks At Mandate On IP And Climate Change, Access For Reading Impaired 14/07/2009 by Kaitlin Mara for Intellectual Property Watch and William New Leave a Comment A conference aimed at sketching out ideas for the World Intellectual Property Organization’s involvement in issues of global public policy kicked off Monday with explorations on the link intellectual property and environmental technology and a separate event devoted to access to reading material for the visually impaired.
July Edition Of IP-Watch Monthly Reporter Now Available 13/07/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The July edition is now available for subscribers.
Interview With David Lammy, UK Minister of Intellectual Property 13/07/2009 by Intellectual Property Watch 3 Comments In a short videocast, Lammy offers his views on global public policy, patent backlogs, patent pools and the role of WIPO.
G8 Public Health Report Cites IP, Innovation 10/07/2009 by Intellectual Property Watch Leave a Comment The Group of 8 industrialised countries plus Russia have issued their report on global public health, and a preliminary report on accountability. The 165-page health report (mostly annexes) encourages implementation of the World Health Organization strategy on intellectual property rights and innovation. It also calls for a review of “options for new innovative financing mechanisms […]
How To Avert The Coming Drug Access Crisis 10/07/2009 by Intellectual Property Watch 2 Comments Interview With Ellen ‘t Hoen, Senior IP Advisor At UNITAID, author of “The Global Politics of Pharmaceutical Monopoly Power.”
Intérêt croissant pour les IG : une réforme internationale est nécessaire selon les partisans 10/07/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment TERUEL, ESPAGNE – Les indications géographiques (IG), qui favorisent une croissance économique durable et offrent une garantie de qualité, servent à la fois les intérêts des producteurs et ceux des consommateurs. Telle est la conclusion d’une réunion à haut niveau qui a rassemblé des partisans des IG en juin. Néanmoins, certains inconvénients au niveau international […]
Special Report: The Swedish Author’s Take On The Catcher In The Rye Copyright Case 10/07/2009 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment COPENHAGEN – Windupbird Publishing owned by Swedish author Fredrik Colting, alias John David California, promises that its books will “tickle your feet and yank your soul.” But American author J.D. Salinger is not amused and has indeed been wound up by Colting’s latest book, which he says is infringing on the copyright of his best-seller, “Catcher in the Rye.” A New York court recently sided with Salinger, but Intellectual Property Watch talked to Colting about why the battle is bound to go on.
G8: Amid Talks Of Climate, Economy, Food And Health Lies IP & Innovation 09/07/2009 by Monika Ermert for Intellectual Property Watch 2 Comments Leaders of the seven biggest economies and Russia (G8) at their annual summit this week in L’Aquila, Italy have made very cautious commitments with regard to the top issue, climate change, but views on intellectual property rights enforcement began to become clear on the second day. The summit so far has addressed issues related to trade, development, terrorism, and also innovation and IP. Statements in the leaders’ Wednesday declaration with regard to intellectual property called for a firm push for the Anti-Counterfeiting Trade Agreement (ACTA), which is unchanged from the past. But the G8 IP Expert Group (IPEG) on Thursday published the results of its discussion in which they went into more detail on some issues.
Too Pricey For A Patent? Glivec Rejected 09/07/2009 by Intellectual Property Watch Leave a Comment Novartis’s patent application for Glivec, a blood cancer drug, was recently ruled not patentable by the Intellectual Property Appellate Board of India (IPAB) for failing to meet the requirements under section 3(d) of the Indian Patent Act, which states that a pharmaceutical derivative must demonstrate enhanced “efficacy” over the prior known molecule, according to Indian […]